Smith, Moore & Co.
- SEC CIK
- 0000200724
- Latest filing
- Aug 12, 2026
NVS holding history
Novartis AG in every 13F filed by Smith, Moore & Co., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
NVS overviewAll 13F holders of NVSFull Q2 2026 holdings
- Shares (Q2 2026)
- 1,870
- Value
- $293.1K
- % of portfolio
- <0.1%
- Quarters held
- 9
- Since Q2 2024
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 1,870 | $293.1K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2026 | 1,870 | $285.7K | <0.1% | −119−6.0% | Reduced | Holders |
| Q4 2025 | 1,989 | $274.2K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2025 | 1,989 | $255.0K | <0.1% | +34+1.7% | Added | Holders |
| Q2 2025 | 1,955 | $236.6K | <0.1% | +8+0.4% | Added | Holders |
| Q1 2025 | 1,947 | $217.0K | <0.1% | −277−12.5% | Reduced | Holders |
| Q4 2024 | 2,224 | $216.4K | <0.1% | +277+14.2% | Added | Holders |
| Q3 2024 | 1,947 | $223.9K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2024 | 1,947 | $207.3K | <0.1% | +1,947 | New | Holders |